SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending intensely as the market anticipates whether the company will raise its bid for Warner Bros. Discovery in response to a rival offer, fueling community debate on whether pursuing the deal or walking away would best benefit the stock amidst ongoing regulatory and political scrutiny.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is surging on strong Anktiva revenue growth and a newly unveiled 3-year plan for global expansion and pipeline acceleration across multiple cancer indications, igniting community discussion around a potential short squeeze and its long-term potential in immunotherapy.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance (PSKY) is actively in a heated bidding war for Warner Bros. Discovery (WBD) with an enhanced offer, compelling WBD to re-enter negotiations despite its current agreement with Netflix (NFLX). The community is fiercely debating whether PSKY's improved terms and perceived smoother regulatory path will ultimately win over WBD shareholders, or if the substantial debt PSKY would incur makes the acquisition untenable.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Vir Biotechnology Inc

Vir Biotechnology is surging due to a strategic collaboration with Astellas for its prostate cancer T-cell engager (VIR-5500) backed by promising Phase 1 data, an earnings beat, and an extended cash runway; however, community sentiment is split between bullish short-squeeze hopes and warnings of a typical post-news pullback.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending amidst a massive sell-off, fueled by investor fears that Anthropic's new AI tool for COBOL modernization threatens a key legacy business and signals broader AI disruption for IT services. However, the community is debating if this is an overreaction, pointing to IBM's internal AI capabilities and deep enterprise client relationships.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending amidst a polarized community debate following a mixed earnings report with raised full-year guidance contrasted by near-term softness, as bulls emphasize continued growth and a substantial share buyback program while bears highlight escalating regulatory challenges and lawsuits surrounding its compounded GLP-1 offerings.

Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in March 2006 and is headquartered in New York, NY.

Protara Therapeutics Inc

Protara Therapeutics is trending after releasing interim Phase 2 data for its TARA-002 bladder cancer treatment, which demonstrated a strong 6-month complete response rate, leading to widespread community discussion about whether the positive clinical results were initially misinterpreted following a recent capital raise. Investors are closely monitoring upcoming presentations for further clarity and potential upside.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is actively discussed amid a recent clinical trial approval for Huntington's Disease and expectations of an expedited regulatory environment for rare disease treatments. The community highlights the stock's significant undervaluation given robust Elevidys sales and its promising siRNA pipeline, fueling speculation around a potential short squeeze or strategic acquisition despite current volatility.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is experiencing high volatility, driving intense community debate between bulls betting on recent institutional integrations, like Coinbase lending and ETF interest, as catalysts for a massive breakout, and bears citing long-term underperformance and predicting further price dips.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is experiencing a dramatic sell-off, with community discussion dominated by fears that AI models pose an existential threat to its core software products, despite recent strong earnings beats and management's efforts to address these concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Calumet (CLMT) Projected to Post Quarterly Earnings on Friday

Calumet (NASDAQ:CLMT) will be releasing its Q4 2025 earnings before the market opens on Friday, February 27. (View Earnings Report at...

Montana Renewables and World Energy Join Forces to Drive Efficiency and Scale in Sustainable Aviation Fuel (SAF) Deliveries

Montana Renewables and World Energy Join Forces to Drive Efficiency and Scale in Sustainable Aviation Fuel (SAF) Deliveries Montana Renewables and World Energy Join Forces to Drive Efficiency and...

Calumet (NASDAQ:CLMT) Reaches New 52-Week High - Here's Why

Calumet (NASDAQ:CLMT) Hits New 1-Year High - What's Next...

Calumet, Inc. (NASDAQ:CLMT) Receives Consensus Rating of "Hold" from Analysts

Shares of Calumet, Inc. (NASDAQ:CLMT - Get Free Report) have been assigned an average rating of "Hold" from the eight research firms that are presently covering the company, MarketBeat reports. One...

Calumet (NASDAQ:CLMT) Shares Up 11.2% - Here's What Happened

Calumet (NASDAQ:CLMT) Shares Up 11.2% - Time to Buy...

Calumet, Inc. to Release Fourth Quarter and Fiscal Year 2025 Earnings on February 27, 2026

Calumet, Inc. to Release Fourth Quarter and Fiscal Year 2025 Earnings on February 27, 2026 Calumet, Inc. to Release Fourth Quarter and Fiscal Year 2025 Earnings on February 27, 2026 PR Newswire...

Calumet (NASDAQ:CLMT) Reaches New 1-Year High - Here's What Happened

Calumet (NASDAQ:CLMT) Hits New 1-Year High - Should You Buy...

Strength Seen in Calumet, Inc. (CLMT): Can Its 5.5% Jump Turn into More Strength?

Calumet, Inc. (CLMT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Great Lakes Advisors LLC Purchases Shares of 169,195 Calumet, Inc. $CLMT

Great Lakes Advisors LLC bought a new position in shares of Calumet, Inc. (NASDAQ:CLMT - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange...

Calumet Extends Senior Secured Revolving Credit Facility to January 2031

Calumet Extends Senior Secured Revolving Credit Facility to January 2031 Calumet Extends Senior Secured Revolving Credit Facility to January 2031 PR Newswire INDIANAPOLIS, Jan. 28, 2026 INDIANAPOLIS...

Calumet, Inc. engages in the manufacturing, formulation, and sale of specialty branded products and renewable fuel. It operates through the following segments: Specialty Products and Solutions, Montana/Renewables, Performance Brands, and Corporate. The Specialty Products & Solutions segment consists of customer-focused solutions and formulation businesses. The Montana/Renewables segment is composed of a Great Falls specialty asphalt facility and Montana Renewables facility. The Performance Brands segment includes Royal Purple, Bel-Ray, and TruFuel. The Corporate segment focuses on the general and administrative expenses not allocated to other segments. The company was founded in 1919 and is headquartered in Indianapolis, IN.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.40	--	--	N/A
Q3 '25	-$0.35	$3.61	1129.21%	BEAT
Q2 '25	-$0.34	-$1.70	-400.00%	MISSED
Q1 '25	-$0.51	-$1.87	-264.17%	MISSED
Q4 '24	-$0.80	-$0.47	40.94%	BEAT

CLMT
Calumet Specialty Products Partners LP

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest CLMT News

CLMTCalumet Specialty Products Partners LP